Omalizumab Subcutaneous and Tigan Intramuscular
Determining the interaction of Omalizumab Subcutaneous and Tigan Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: trimethobenzamide
Brand name: Benzacot, Ticon, Tigan
Synonyms: Tigan (oral/injection), Tigan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Tigan oral/injection
- Omalizumab Subcutaneous-Tigecycline
- Omalizumab Subcutaneous-Tigecycline Intravenous
- Omalizumab Subcutaneous-Tiglutik
- Omalizumab Subcutaneous-Tikosyn
- Omalizumab Subcutaneous-Tilade
- Tigan Intramuscular-Ombitasvir, Paritaprevir, and Ritonavir
- Tigan Intramuscular-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Tigan Intramuscular-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Tigan Intramuscular-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Tigan Intramuscular-Omeclamox-Pak
- Tigan Intramuscular-Omega-3 Fatty Acid Capsules